BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 7666325)

  • 1. Neuroblastoma.
    Davidoff AM
    Semin Pediatr Surg; 2012 Feb; 21(1):2-14. PubMed ID: 22248965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric DNA analysis of neuroblastoma: prognostic significance of DNA ploidy in unfavorable group.
    Naito M; Iwafuchi M; Ohsawa Y; Uchiyama M; Hirota M; Matsuda Y; Iinuma Y
    J Pediatr Surg; 1991 Jul; 26(7):834-7. PubMed ID: 1895194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
    Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello MA; Plouvier E; Lemerle J; Riou G; Bénard J
    J Clin Oncol; 1991 Aug; 9(8):1371-5. PubMed ID: 2072140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Features and outcome of neuroblastoma detected before birth.
    Granata C; Fagnani AM; Gambini C; Boglino C; Bagnulo S; Cecchetto G; Federici S; Inserra A; Michelazzi A; Riccipetitoni G; Rizzo A; Tamaro P; Jasonni V; De Bernardi B
    J Pediatr Surg; 2000 Jan; 35(1):88-91. PubMed ID: 10646781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
    Bagatell R; Rumcheva P; London WB; Cohn SL; Look AT; Brodeur GM; Frantz C; Joshi V; Thorner P; Rao PV; Castleberry R; Bowman LC
    J Clin Oncol; 2005 Dec; 23(34):8819-27. PubMed ID: 16314642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J; Bénard J; DeVathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; Lemerle J; Riou G
    Prog Clin Biol Res; 1991; 366():107-13. PubMed ID: 2068130
    [No Abstract]   [Full Text] [Related]  

  • 7. Retrospective analysis of biological factors in a recurrent IV-S neuroblastoma with intermediate-grade malignancy.
    Ikeda H; Nagashima K; Matsuyama S; Suzuki N; Takahashi A; Kuroiwa M; Hirato J
    J Pediatr Surg; 1995 Jun; 30(6):866-9. PubMed ID: 7666325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable histology, MYCN-amplified 4S neonatal neuroblastoma.
    Chan EL; Harris RE; Emery KH; Gelfand MJ; Collins MH; Gruppo RA
    Pediatr Blood Cancer; 2007 Apr; 48(4):479-82. PubMed ID: 16333837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatally diagnosed neuroblastoma.
    Acharya S; Jayabose S; Kogan SJ; Tugal O; Beneck D; Leslie D; Slim M
    Cancer; 1997 Jul; 80(2):304-10. PubMed ID: 9217044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome.
    Grosfeld JL; Rescorla FJ; West KW; Goldman J
    Semin Pediatr Surg; 1993 Feb; 2(1):37-46. PubMed ID: 8062021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [4S neuroblastoma with bilateral adrenal tumors].
    Kerdudo C; Corradini N; Michon J; Leverger G
    Arch Pediatr; 2004 Dec; 11(12):1450-6. PubMed ID: 15596333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies.
    van Noesel MM; Hählen K; Hakvoort-Cammel FG; Egeler RM
    Cancer; 1997 Sep; 80(5):834-43. PubMed ID: 9307181
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.